In this presentation, Dr. Kamyar Hadian (head of the and Screening Platform’ at the HelmholtzZentrum München in Munich/Germany) talk about use in – and microtissue-based assays.

has highly emerged in the past years. Especially High-Content Screening (HCS) has gained strong acceptance in the field of target validation and compounds screening as a method to follow more innovative and sophisticated assays …